Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lunai Bioworks Inc.RENB · Entity 7981 | Director | January 21, 2025 | February 25, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lunai Bioworks Inc.
Report date January 21, 2025 · Filed February 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 250,000 |
Reported balance
After 2025-01-21 transaction · row 1
1 source rowRow 1 · 2025-01-21 · Grant · Acquired 250,000 · Balance 250,000 F1: These restricted shares vest in five equal annual installments beginning on December 30, 2025. |
| Option to purchase shares of common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.72 · Expires 2035-01-21 | Direct | 1,000,000 |
Reported balance
After 2025-01-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-01-21 · Grant · Acquired 1,000,000 · Balance 1,000,000 F2: This option vests in five equal annual installments beginning on December 30, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted shares vest in five equal annual installments beginning on December 30, 2025.
F2: This option vests in five equal annual installments beginning on December 30, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2025 Filed Feb 25, 2025 13:33 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 1,000,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001731122-25-000295 · ownership.xml · derivative · entry 2 van Tilburg Maurice · CIK 0002043498 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common stock · 1,000,000 shares Expires 2035-01-21 F2 · derivative.exercise_date: This option vests in five equal annual installments beginning on December 30, 2025. Read SEC document |
| January 21, 2025 Filed Feb 25, 2025 13:33 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-25-000295 · ownership.xml · nonDerivative · entry 1 van Tilburg Maurice · CIK 0002043498 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 F1 · shares: These restricted shares vest in five equal annual installments beginning on December 30, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.